The federal suit filed in Massachusetts accuses drug makers Sanofi, Novo Nordisk and Eli Lilly of raising the list prices of their products “in perfect lock step” for years.
The accusations center on the shadowy rebate system between drug makers and pharmacy benefit managers, which this news outlet has been investigating.
Read more about the lawsuit: Insulin makers accused of price-fixing scheme
More from our investigation:
In Other News
1
Wright State names Sargent to replace Nagy as coach
2
National Air Force Museum prepares eclipse event for up to 30K
3
More New Lebanon village staff fired; manager sues, police chief calls...
4
Endangered Missing Alert issued for missing Trenton man with dementia
5
Owner of Brock Masterson’s Catering retires after 38 years: ‘It’s been...
About the Author